Shypd.aiThe largest open index of AI toolsInSilicoTrials is a healthcare AI tool that democratizes simulations in drug development. It provides an end-to-end in silico platform for rigorous, science-backed drug development, optimizing pre-clinical, clinical, and post-approval decisions.
Trending
About
InSilicoTrials offers an advanced end-to-end in silico platform designed to revolutionize drug development by integrating mechanistic models, AI, digital twins, synthetic data, and operations forecasting. The platform supports both scientific and operational aspects of clinical trials, enabling synthetic patient generation, scenario comparisons for dosing, sample size, and adaptive designs. It includes a Model Library, Data Library, data Integrator, Workflow Builder, Clinical Trial Simulator, and Output Dashboard, supporting various models like safety, efficacy, biomarkers, and AI/ML. A key differentiator is IRIS, a multi-agentic simulation workflow orchestration system that leverages AI to search external sources, interpret data, make recommendations, and independently launch new simulations, significantly de-risking every stage from preclinical to post-approval.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check insilicotrials.com for current pricing.
FAQs
Trending
Also listed in
